The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 closed up 0.4% – thanks to a very small rise in Australia’s latest Gross Domestic Product data.

Quarterly GDP rose just 0.1%, which is the slowest pace of GDP growth in one-and-a-half-years. 

As far as the sectors went today, Telecommunications led, gaining around 2%. Materials felt some pain, shedding more than 1.1%  

In the Green

In that telecommunications sector, Seek (ASX:SEK) was one of the best performers, up nearly 5% on news it’s selling all of its Latin American assets.

It’s selling OCC Mexico and Brasil Online to Red Arbour Holding in a $127.7 million deal (US$85 million).

The disposals will result in a net loss after tax of up to $35 million dollars, however, the proceeds will reduce Seek’s debt position. 

Seek closed at $23.78.

The Calmer Co (ASX:CCO) jumped 116% on reporting its ecommerce sales are up 45 per cent to $16,000 a day. It reported 10 months of consecutive sales growth, including across its Coles supermarket lines.

The Calmer Co closed at 1.3 cents.

And radio pharmaceutical company, Cyclopharm’s (ASX:CYC) gained 21% on news its FDA-approved nuclear medicine diagnostic ventilation imaging agent Technegas will receive full and direct government reimbursement.

It’s been granted what’s called Pass-Through Status from CMS, the US government authority which sets healthcare rebate rates.

Cyclopharm closed at $1.69.

In the Red

BHP Group (ASX:BHP) shed a further 0.85% today, after both iron ore and copper prices turned down internationally last night. There’s more iron ore coming from South Africa and some analysts tip there could be a further negative price correction.

BHP closed at $43.90. It wasn’t alone amongst the commodity giants: Fortescue (ASX:FMG) also shed .8% and Rio Tinto (ASX:RIO) fell further – dropping about 1.5%.

Immutep (ASX:IMM) was down nearly 9% after announcing it’s raising over $100 million – mostly through an institutional placement raising $89.6 million at 38c a share.

It’ll open a retail entitlement to raise the remaining $10.6 million on Friday. The funds are to progress Phase III clinical trials for its lung cancer and Phase II breast cancer treatment.

Shares were holding up above the raise price though… closing at 41 cents.

And 5E Advanced Materials (ASX:5EA) dropped 2.2% on the resignation of its chief executive officer, Susan Brennan, who was in the position for 13-months.

The boron and lithium company is working in Southern California. Its CFO Paul Whyble (Weibel) will step into the role immediately.

5EA closed at 22 cents.

More From The Market Online
The Market Online Video

Market Close: ASX 200 rallies as risk appetite returns, but business confidence weakens

The Australian sharemarket finished firmly higher today with the S&P/ASX 200 adding 106.50 points, or 1.18%, to close at 9,136.20.

EVE Health Group signs Australian compounding agreement for rapidly rising Men’s Health issue

EVE Health Group has signed an agreement with Optimal Pharmacy Plus Stafford aimed at the Australian…

Nanoveu’s EMASS signs DigiKey as Global Distributor for ECS-DoT-22

Nanoveu's wholly-owned subsidiary EMASS has signed DigiKey as its global distributor for ECS-DoT-22 system.
The Market Online Video

Wealth Within: Wall Street Tech Sinks While ASX Tech Soars

Wall Street’s technology stocks have been hammered, with the Nasdaq plunging 5.5 per cent in a single session and Nvidia falling more tha…